There is a fantastic event coming up that will be of interest to any Chemists interested in drug discovery.
The NSW Drug Discovery Forum is jointly organised by the University of Sydney and MTPConnect, with RACI member and Award winner, Professor Michael Kassiou as the Chair of the organising committee.
This state-wide event will be held on the 28th and 29th October 2024 and is now open to applications from all academic researchers across the state. During the forum, presenters from universities, MRIs and healthcare will present their early-stage research to an expert panel of industry and investors to receive guidance and feedback on how to further develop their project. The panel members include representatives from Johnson and Johnson, Abbvie, Proto Axiom and IP group.
This is an especially great opportunity for ECRs and people working in regional universities. Details for applications for presentation of your work are below.
Industry engagement is essential for the development of life-changing drugs. The NSW Drug Discovery Forum aims to amplify research translation for researchers based in NSW.
Apply to present your pre-IP and/or unlicensed research to a panel of pharmaceutical and investment companies, including Johnson and Johnson, Roche, Brandon Capital and IP Group, to receive feedback and make connections.
On October 28 and 29, the panel will hear presentations in all aspects of pre-IP drug discovery, from small molecules to impactful biologics to address:
|
Terms & Conditions: All information included in the application and forum presentation must be strictly non-confidential. Applicants must receive clearance to submit and present their application from their tech transfer offices as a condition and the organisers will not be responsible for maintaining the confidentiality of any confidential material is submitted or presented. Applications are through the secure data capture platform, REDCAP and will be reviewed by an independent review panel selected with support from MTPConnect.
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Sign up to receive future emails from the Drug Discovery Forum.
|
|
|